Pharmaceuticals Department Secretary urges medical device industry to provide greater input in shaping India’s regulatory framework
- IBEF
- August 24, 2026
Department of Pharmaceuticals Secretary Mr. Manoj Joshi urged the medical device industry to play a more active role in shaping India’s regulatory framework at the CII Global MedTech Summit in New Delhi. He noted that industry participation in regulatory discussions remains limited and called for stronger dialogue between the government and medical device manufacturers to develop a more effective regulatory ecosystem. Mr. Joshi emphasised that medical devices require a regulatory framework distinct from pharmaceuticals as they are engineering products whose quality and performance depend on factors including product design, manufacturing processes and testing standards. He also highlighted the importance of strengthening testing mechanisms for both medical device designs and finished products to ensure quality and reliability.
Greater industry participation in regulatory discussions is expected to support the development of a more responsive and industry-aligned framework for India’s medical devices sector. Stronger government-industry collaboration can help address regulatory requirements while encouraging improvements in product quality, testing and manufacturing practices. The emphasis on design-level and finished-product testing also underlines the need for comprehensive quality assurance across the medical device value chain. The initiative is expected to contribute to the development of a stronger domestic medical technology ecosystem and support the sector’s continued growth and innovation in India.
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.
Partners
